Andrew Fein

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Andrew Fein works at HC WAINWRIGHT and is covering the the Healthcare sector with 425 price targets and ratings documented since 2013 spanning on 47 stocks. Previously, Andrew Fein worked at CHARDAN CAPITAL.

Andrew Fein's average stock forecast success ratio is 33.39% with an average time for price targets to be met of 173.74 days.

Most recent stock forecast was given on ZNTL, Zentalis Pharmaceuticals Inc at 26-May-2023.

Wall Street Analyst Andrew Fein

Analyst best performing recommendations are on CRBP (CORBUS PHARMACEUTICALS HOLDINGS, INC).
The best stock recommendation documented was for DNLI (DENALI THERAPEUTICS INC) at 11/6/2020. The price target of $65 was fulfilled within 5 days with a profit of $10.76 (19.84%) receiving and performance score of 39.68.

Average potential price target upside

Currently, out of the existing stock ratings of Andrew Fein - 8 which are a Buy (100%)

ACAD ANNX BIIB BLU BPMC CRTX DBVT ELOX EPZM FHTX IMAB MRUS OCUP PRQR SGEN AMLX DCPH GMTX RUBY TARA UTHR AMRN SYRS ZNTL CPRX CCCC ARVN LQDA ABOS ACIU CRBP DNLI FULC KALV MEIP NBIX PEPG PRTA PULM STOK STRO TCRX THRX UBX VIGL VRTX WVE

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

26

$2.21 (9.29%)

32

9 days ago

4/7 (57.14%)

$6.71 (26.73%)

285

Buy

28

$4.21 (17.70%)

28

22 days ago

5/10 (50%)

$9.79 (40.33%)

175

Buy

23

$-0.79 (-3.32%)

35

22 days ago

8/14 (57.14%)

$11.27 (50.83%)

188

Buy

27

$3.21 (13.49%)

27

22 days ago

3/15 (20%)

$9.76 (40.41%)

186

Hold

20

$-3.79 (-15.93%)

20

1 months 17 days ago

7/11 (63.64%)

$3.28 (11.66%)

51

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership